MPEP § 608.02(d) — Complete Illustration in Drawings (Annotated Rules)

§608.02(d) Complete Illustration in Drawings

USPTO MPEP version: BlueIron's Update: 2025-12-31

This page consolidates and annotates all enforceable requirements under MPEP § 608.02(d), including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.

Complete Illustration in Drawings

This section addresses Complete Illustration in Drawings. Primary authority: 35 U.S.C. 111, 35 U.S.C. 371, and 37 CFR 1.83(a). Contains: 1 guidance statement and 1 other statement.

Key Rules

Topic

Sequence Listing Format

2 rules
StatutoryRecommendedAlways
[mpep-608-02-d-dd519f66f3b7c7662d5928bf]
Tables and Sequences Not to Be Duplicated in Drawings
Note:
Tables from the specification and sequences from sequence listings should not be included in the drawings of a nonprovisional application.

(a) The drawing in a nonprovisional application must show every feature of the invention specified in the claims. However, conventional features disclosed in the description and claims, where their detailed illustration is not essential for a proper understanding of the invention, should be illustrated in the drawing in the form of a graphical drawing symbol or a labeled representation (e.g., a labeled rectangular box). In addition, tables that are included in the specification and sequences that are included in sequence listings should not be duplicated in the drawings.

Jump to MPEP Source · 37 CFR 1.83Sequence Listing FormatPatent Application ContentSequence Listing Requirements
StatutoryRecommendedAlways
[mpep-608-02-d-f8502c6efcf1c41a0236b359]
Sequence Listing Not In Both Drawings and Description
Note:
An application should not include a sequence listing in both the drawings and descriptive portion of the specification.

If an application filed under 35 U.S.C. 111 or under 35 U.S.C. 371 includes a sequence listing or a table, such a sequence listing or table should not be included in both the drawings and the descriptive portion of the specification. 37 CFR 1.83(a) and 1.58(a).

Jump to MPEP Source · 37 CFR 1.83(a)Sequence Listing FormatPatent Cooperation TreatySequence Listing Requirements
Topic

Final Office Action

2 rules
StatutoryInformativeAlways
[mpep-608-02-d-0c367c4404c55ce93c3f95d9]
Drawings Objections Not Held In Abeyance
Note:
Objections to drawings in utility or plant applications must be addressed, not held pending further action.

2. Unless applicant is otherwise notified in an Office action, objections to the drawings in a utility or plant application will not be held in abeyance, and a request to hold objections to the drawings in abeyance will not be considered a bona fide attempt to advance the application to final action. See 37 CFR 1.85(a).

37 CFR 1.77 · 37 CFR 1.85(a)Final Office ActionTypes of Office ActionsExaminer's Action (37 CFR 1.104)
StatutoryInformativeAlways
[mpep-608-02-d-6979b7e6a1683935dfea0952]
Drawings Objections Not Held In Abeyance
Note:
Objections to drawings in utility or plant applications must be addressed, not held pending further action.

2. Unless applicant is otherwise notified in an Office action, objections to the drawings in a utility or plant application will not be held in abeyance, and a request to hold objections to the drawings in abeyance will not be considered a bona fide attempt to advance the application to final action. See 37 CFR 1.85(a).

37 CFR 1.77 · 37 CFR 1.85(a)Final Office ActionTypes of Office ActionsExaminer's Action (37 CFR 1.104)
Topic

Drawing Symbols and Legends

1 rules
StatutoryRequiredAlways
[mpep-608-02-d-f3009d170811646ced35154c]
Conventional Features Must Be Shown as Symbols
Note:
Nonprovisional application drawings must depict specified invention features, but conventional ones can be represented by symbols if detailed illustration is not necessary.

(a) The drawing in a nonprovisional application must show every feature of the invention specified in the claims. However, conventional features disclosed in the description and claims, where their detailed illustration is not essential for a proper understanding of the invention, should be illustrated in the drawing in the form of a graphical drawing symbol or a labeled representation (e.g., a labeled rectangular box). In addition, tables that are included in the specification and sequences that are included in sequence listings should not be duplicated in the drawings.

Jump to MPEP Source · 37 CFR 1.83Drawing Symbols and LegendsRequired Drawing Content
Topic

PCT Drawing Requirements

1 rules
StatutoryInformativeAlways
[mpep-608-02-d-e73033fcecf416215f03cf52]
Sequence Listing Must Not Be Included In Both Drawings and Description
Note:
An application should not include a sequence listing in both the drawings and descriptive portion of the specification.

If an application filed under 35 U.S.C. 111 or under 35 U.S.C. 371 includes a sequence listing or a table, such a sequence listing or table should not be included in both the drawings and the descriptive portion of the specification. 37 CFR 1.83(a) and 1.58(a).

Jump to MPEP Source · 37 CFR 1.83(a)PCT Drawing RequirementsPCT DrawingsSequence Listing Format

Examiner Form Paragraphs

Examiner form paragraphs are standard language that you might see in an Office Action or communication from the USPTO. Examiners have latitude to change the form paragraphs, but you will often see this exact language.

¶ 6.36 ¶ 6.36 Drawings Do Not Show Claimed Subject Matter

The drawings are objected to under 37 CFR 1.83(a) . The drawings must show every feature of the invention specified in the claims. Therefore, the [1] must be shown or the feature(s) canceled from the claim(s). No new matter should be entered.

Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either "Replacement Sheet" or "New Sheet" pursuant to 37 CFR 1.121(d) . If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance.

Examiner Note

In bracket 1, insert the features that must be shown.

Citations

Primary topicCitation
PCT Drawing Requirements
Sequence Listing Format
35 U.S.C. § 111
PCT Drawing Requirements
Sequence Listing Format
35 U.S.C. § 371
37 CFR § 1.81(d)
PCT Drawing Requirements
Sequence Listing Format
37 CFR § 1.83(a)
Final Office Action37 CFR § 1.85(a)
MPEP § 608.02
Form Paragraph § 6.22.01
Form Paragraph § 6.27

Source Text from USPTO’s MPEP

This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.

BlueIron Last Updated: 2025-12-31